Trinity Biotech plc

NasdaqGS:TRIB 株式レポート

時価総額:US$10.6m

Trinity Biotech 過去の業績

過去 基準チェック /06

Trinity Biotechの収益は年間平均-12.6%の割合で減少していますが、 Medical Equipment業界の収益は年間 増加しています。収益は年間12% 11.5%割合で 減少しています。

主要情報

-12.6%

収益成長率

6.8%

EPS成長率

Medical Equipment 業界の成長8.9%
収益成長率-11.5%
株主資本利益率n/a
ネット・マージン-34.4%
前回の決算情報30 Sep 2024

最近の業績更新

Recent updates

Investors Give Trinity Biotech plc (NASDAQ:TRIB) Shares A 38% Hiding

Sep 25
Investors Give Trinity Biotech plc (NASDAQ:TRIB) Shares A 38% Hiding

A Piece Of The Puzzle Missing From Trinity Biotech plc's (NASDAQ:TRIB) 35% Share Price Climb

Aug 07
A Piece Of The Puzzle Missing From Trinity Biotech plc's (NASDAQ:TRIB) 35% Share Price Climb

The Market Lifts Trinity Biotech plc (NASDAQ:TRIB) Shares 34% But It Can Do More

Jun 11
The Market Lifts Trinity Biotech plc (NASDAQ:TRIB) Shares 34% But It Can Do More

Investors Don't See Light At End Of Trinity Biotech plc's (NASDAQ:TRIB) Tunnel And Push Stock Down 27%

Mar 02
Investors Don't See Light At End Of Trinity Biotech plc's (NASDAQ:TRIB) Tunnel And Push Stock Down 27%

Trinity Biotech plc's (NASDAQ:TRIB) Shares Bounce 31% But Its Business Still Trails The Industry

Dec 18
Trinity Biotech plc's (NASDAQ:TRIB) Shares Bounce 31% But Its Business Still Trails The Industry

A Look At The Fair Value Of Trinity Biotech plc (NASDAQ:TRIB)

Sep 12
A Look At The Fair Value Of Trinity Biotech plc (NASDAQ:TRIB)

Should You Investigate Trinity Biotech plc (NASDAQ:TRIB) At US$0.80?

Aug 08
Should You Investigate Trinity Biotech plc (NASDAQ:TRIB) At US$0.80?

Insufficient Growth At Trinity Biotech plc (NASDAQ:TRIB) Hampers Share Price

Jun 09
Insufficient Growth At Trinity Biotech plc (NASDAQ:TRIB) Hampers Share Price

Calculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB)

Apr 23
Calculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB)

This Broker Just Slashed Their Trinity Biotech plc (NASDAQ:TRIB) Earnings Forecasts

Apr 23
This Broker Just Slashed Their Trinity Biotech plc (NASDAQ:TRIB) Earnings Forecasts

Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Mar 01
Does Trinity Biotech (NASDAQ:TRIB) Have A Healthy Balance Sheet?

Trinity Biotech appoints former GE executive Aris Kekedjian as CEO

Oct 03

At US$1.22, Is Trinity Biotech plc (NASDAQ:TRIB) Worth Looking At Closely?

Sep 01
At US$1.22, Is Trinity Biotech plc (NASDAQ:TRIB) Worth Looking At Closely?

Trinity Biotech GAAP EPADS of -50c, revenue of $18.78M misses by $1.22M

Jun 30

収支内訳

Trinity Biotech の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqGS:TRIB 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Sep 2459-20274
30 Jun 2459-22294
31 Mar 2457-34305
31 Dec 2357-37314
30 Sep 2371-39364
30 Jun 2354-46304
31 Mar 2374-34324
31 Dec 2263-44274
30 Sep 2276-32254
30 Jun 2279-22254
31 Mar 2286-13244
31 Dec 2181-2234
30 Sep 21106-8265
30 Jun 21116-2275
31 Mar 21106-2255
31 Dec 20102-6255
30 Sep 2091-20305
30 Jun 2083-27315
31 Mar 2090-31275
31 Dec 1990-29335
30 Sep 1994-30285
30 Jun 1993-29285
31 Mar 1995-23295
31 Dec 1897-23295
30 Sep 1897-39306
30 Jun 1899-40316
31 Mar 1899-40316
31 Dec 1799-39316
30 Sep 1798-36305
30 Jun 1799-37305
31 Mar 17100-36305
31 Dec 16100-39305
30 Sep 161013295
30 Jun 1610116305
31 Mar 169816285
31 Dec 1510022285
30 Sep 1510123315
30 Jun 1510315314
31 Mar 1510517304
31 Dec 1410515304
30 Sep 1410318304
30 Jun 1410010294
31 Mar 149510284
31 Dec 139110274

質の高い収益: TRIBは現在利益が出ていません。

利益率の向上: TRIBは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: TRIBは利益が出ておらず、過去 5 年間で損失は年間12.6%の割合で増加しています。

成長の加速: TRIBの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: TRIBは利益が出ていないため、過去 1 年間の収益成長をMedical Equipment業界 ( 12.9% ) と比較することは困難です。


株主資本利益率

高いROE: TRIBの負債は資産を上回っているため、自己資本利益率を計算することは困難です。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘